Market Tracker

12/06 2:46pm ET

Bristol-Myers Squibb Co (NYSE:BMY)

55.88
BATS BZX Real-Time Price
As of 2:46pm ET
 +0.33 / +0.59%
Today’s Change
49.03
Today|||52-Week Range
77.12
-18.77%
Year-to-Date
Bristol-Myers Reports Data from Opdivo Combination Studies
10:07am / Zacks.com - Paid Partner Content
Heat Biologics Stock Falls on Negative Bladder Cancer Data
Dec 01 / Zacks.com - Paid Partner Content
3 Beaten-Up Healthcare Stocks: Are They Bargains?
8:36am / MotleyFool.com - Paid Partner Content
3 Ways Organovo Holdings, Inc. Plans to Grow Exponentially for Years to Come
Dec 01 / MotleyFool.com - Paid Partner Content
Why Bristol-Myers Squibb Co. Stock Surged in November
Dec 03 / MotleyFool.com - Paid Partner Content
ARIAD's Leukemia Drug Iclusig Gets Full Approval in U.S.
Nov 30 / Zacks.com - Paid Partner Content
Why Exelixis Was a Top Stock in 2016 So Far
Dec 02 / MotleyFool.com - Paid Partner Content
Healthcare Bill Up for House Vote Wed. Hailed as Game-Changer, Blasted as Pharma Hand...
Nov 29 / TheStreet.com - Paid Partner Content
Pharma Stock Roundup: Nivalis Falls on Study Data, Priority Reviews for Merck's Keytr...
Dec 02 / Zacks.com - Paid Partner Content
Is Bristol-Myers Feeling Better? Not Really
Nov 29 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close55.55
Today’s open55.73
Day’s range55.57 - 55.93
Volume298,982
Average volume (3 months)13,892,433
Market cap$92.8B
Dividend yield2.72%
Data as of 2:46pm ET, 12/06/2016

Growth & Valuation

Earnings growth (last year)-22.50%
Earnings growth (this year)+42.29%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+4.29%
P/E ratio27.9
Price/Sales6.97
Price/Book6.47

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+0.09+0.23%
CELGCelgene+1.29+1.11%
ABBVAbbVie+0.78+1.28%
SNYSanofi-0.25-0.61%
Data as of 2:46pm ET, 12/06/2016

Financials

Next reporting dateJanuary 26, 2017
EPS forecast (this quarter)$0.66
Annual revenue (last year)$16.6B
Annual profit (last year)$1.6B
Net profit margin9.45%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Giovanni Caforio
Chief Financial Officer &
Executive Vice President
Charles A. Bancroft
Corporate headquarters
New York, New York

Forecasts